IBTA Ibotta, Inc.

$22.37

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/21/2025

About Ibotta, Inc.

Ibotta, Inc. is a technology company that offers Ibotta Performance Network (IPN) that allows consumer packaged goods brands to deliver digital promotions to consumers. The company is headquartered in Denver, Colorado.

Website: https://www.ibotta.com

Sector
TRADE & SERVICES
Industry
SERVICES-ADVERTISING
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1538379
Address
1801 CALIFORNIA STREET, SUITE 400, DENVER, CO, UNITED STATES
Valuation
Market Cap
$1.26B
P/E Ratio
18.63
PEG Ratio
nan
Price to Book
3.08
Performance
EPS
$2.56
Dividend Yield
—
Profit Margin
18.70%
ROE
28.30%
Technicals
50D MA
$49.30
200D MA
$61.73
52W High
$110.95
52W Low
$31.40
Fundamentals
Shares Outstanding
26M
Target Price
$50.25
Beta
nan

IBTA EPS Estimates vs Actual

● Estimated
● Actual

IBTA News & Sentiment

Nov 19, 2025 • Benzinga NEUTRAL
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. ( NASDAQ: CYTK ) ; Fortrea Holdings, Inc. ( NASDAQ: FTRE ) ; Ibotta, Inc. ( NYSE: IBTA ) ; and Stride, Inc. ( NYSE: LRN ) : Grabar Law Office is Investigating Claims on Your Behalf - Fortrea Holdings ( NASDAQ:FTRE ) , Cytokinetics ( NASDAQ:CYTK )
PHILADELPHIA, Nov. 19, 2025 ( GLOBE NEWSWIRE ) -- Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. ( NASDAQ:CYTK ) . The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
Nov 18, 2025 • Benzinga NEUTRAL
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. ( NASDAQ: CYTK ) ; enCore Energy Corp. ( NASDAQ: EU ) ; Fluor Corporation ( NYSE: FLR ) ; Fortrea Holdings, Inc. ( NASDAQ: FTRE ) ; and Ibotta, Inc. ( NYSE: IBTA ) : Grabar Law Office is Investigating Claims on Your Behalf - enCore Energy ( NASDAQ:EU ) , Cytokinetics ( NASDAQ:CYTK )
PHILADELPHIA, Nov. 18, 2025 ( GLOBE NEWSWIRE ) -- Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. ( NASDAQ:CYTK ) . The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
Nov 17, 2025 • Benzinga NEUTRAL
Important Notice to Long-Term Shareholders of enCore Energy Corp. ( NASDAQ: EU ) ; Fluor Corporation ( NYSE: FLR ) ; Fortrea Holdings, Inc. ( NASDAQ: FTRE ) ; and Ibotta, Inc. ( NYSE: IBTA ) : Grabar Law Office is Investigating Claims on Your Behalf - enCore Energy ( NASDAQ:EU ) , Fluor ( NYSE:FLR )
PHILADELPHIA, Nov. 17, 2025 ( GLOBE NEWSWIRE ) -- Grabar Law Office is investigating claims on behalf of shareholders of enCore Energy Corp. ( NASDAQ:EU ) . The investigation concerns whether certain officers and directors breached their fiduciary duties.
Nov 17, 2025 • Benzinga NEUTRAL
Johnson Fistel, PLLP Investigates Claims on Behalf of Ibotta, Inc. Long-Term Shareholders - Ibotta ( NYSE:IBTA )
SAN DIEGO, Nov. 17, 2025 ( GLOBE NEWSWIRE ) -- Johnson Fistel, PLLP is investigating potential claims on behalf of Ibotta, Inc. ( NYSE:IBTA ) shareholders against certain of its officers and directors who may have breached the fiduciary duties they owed to the Company.
Nov 13, 2025 • Motley Fool SOMEWHAT-BULLISH
Ibotta ( IBTA ) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Nov. 12, 2025 at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading ...
Nov 13, 2025 • Benzinga NEUTRAL
Ardent Health, KinderCare Learning, Ibotta And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Absci ( NASDAQ:ABSI ) , Alvotech ( NASDAQ:ALVO )
U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Thursday. Shares of Ardent Health, Inc. ( NYSE:ARDT ) fell sharply in pre-market trading after the company reported third-quarter earnings below estimates and lowered its FY2025 GAAP EPS guidance.
Sentiment Snapshot

Average Sentiment Score:

0.051
50 articles with scored sentiment

Overall Sentiment:

Neutral

IBTA Reported Earnings

Aug 13, 2025
Jun 30, 2025 (Post market)
-0.08 Surprise
  • Reported EPS: $0.49
  • Estimate: $0.57
  • Whisper: —
  • Surprise %: -14.0%
May 14, 2025
Mar 31, 2025 (Post market)
-0.03 Surprise
  • Reported EPS: $0.36
  • Estimate: $0.39
  • Whisper: —
  • Surprise %: -7.7%
Feb 26, 2025
Dec 31, 2024 (Post market)
1.83 Surprise
  • Reported EPS: $2.27
  • Estimate: $0.44
  • Whisper: —
  • Surprise %: 415.9%
Nov 13, 2024
Sep 30, 2024 (Post market)
0.25 Surprise
  • Reported EPS: $0.94
  • Estimate: $0.69
  • Whisper: —
  • Surprise %: 36.2%
Aug 13, 2024
Jun 30, 2024 (Post market)
-0.47 Surprise
  • Reported EPS: $-1.32
  • Estimate: $-0.85
  • Whisper: —
  • Surprise %: -55.3%
May 30, 2024
Mar 31, 2024 (Post market)
0.0 Surprise
  • Reported EPS: $0.33
  • Estimate: $0.33
  • Whisper: —
  • Surprise %: 0.0%

Financials